Paul C. Grimm

Publication Details

  • Multicenter trial of everolimus in pediatric renal transplant recipients: Results at three year PEDIATRIC TRANSPLANTATION Ettenger, R., Hoyer, P., Grimm, P., Webb, N., Loirat, C., Mahan, J. D., Mentser, M., Niaudet, P., Offner, G., Vandamme-Lombaerts, R., Hexham, J. M. 2008; 12 (4): 456-463


    There are few prospective clinical trials of mTOR inhibitors (or proliferation signal inhibitors) combined with CNI inhibitors in de novo pediatric renal transplantation. Results reported here are from a multicenter, open-label study in de novo pediatric renal transplant patients (

    View details for DOI 10.1111/j.1399-3046.2007.00832.x

    View details for Web of Science ID 000255551700015

    View details for PubMedID 18466433

Stanford Medicine Resources:

Footer Links: